Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Pfizer Inc.

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Pfizer Inc. with status Current. The shortage was first posted on 12/15/2021.

Shortage Details

Status
Current
Company
Pfizer Inc.
Package NDC
0009-0280-52
Dosage Form
Injection
Presentation
Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)
Initial Posting
12/15/2021
Revised Date